• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化扩散加权 MRI 成像,以诊断转移性和骨髓瘤骨病,并评估其可重复性。

Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility.

机构信息

Cancer Research UK Clinical Magnetic Resonance Research Group, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Downs Road, Surrey, SM2 5PT, UK.

出版信息

Eur Radiol. 2011 Aug;21(8):1713-8. doi: 10.1007/s00330-011-2116-4. Epub 2011 Apr 7.

DOI:10.1007/s00330-011-2116-4
PMID:21472473
Abstract

OBJECTIVES

To establish normal bone marrow values of apparent diffusion coefficient (ADC) over an age range, compare them with metastatic and myelomatous involvement, to establish reproducibility and to optimise b values.

METHODS

The ADCs of bone marrow in 7 volunteers (mean age 29.7 years), 34 volunteers (mean age 63.3 years) and 43 patients with metastatic and myelomatous involvement (mean age 65.5 years) were measured. In 9 volunteers diffusion weighted MRI was repeated within 7 days. b values were derived to optimise contrast between normal and pathological marrow.

RESULTS

The mean ADC of bone marrow in younger volunteers was significantly higher than that of older volunteers. The coefficient of reproducibility was 14.8%. The ADC mean of metastatic and myeloma bone disease was 1054 + / -456 x 10⁻⁶mm²s⁻¹. An ADC threshold of 655 × 10(-6) mm(2)s(-1) separated normal and abnormal marrow with a sensitivity and specificity of 90% and 93% respectively. Contrast between normal and abnormal marrow was optimal at b = 1389 smm(-2).

CONCLUSION

The reproducibility of ADC measurements in bone is equivalent to published data for soft tissue with a high sensitivity and specificity for separating abnormal from age matched normal bone marrow. A b value of around 1,400 smm(-2) is optimal for imaging bone marrow.

摘要

目的

建立表观扩散系数(ADC)在年龄范围内的正常骨髓值,将其与转移性和骨髓瘤性受累进行比较,以确定可重复性并优化 b 值。

方法

测量了 7 名志愿者(平均年龄 29.7 岁)、34 名志愿者(平均年龄 63.3 岁)和 43 名转移性和骨髓瘤性受累患者(平均年龄 65.5 岁)的骨髓 ADC 值。在 9 名志愿者中,在 7 天内重复进行了扩散加权 MRI。得出了 b 值以优化正常和病理性骨髓之间的对比度。

结果

年轻志愿者的骨髓 ADC 平均值明显高于年长志愿者。可重复性系数为 14.8%。转移性和骨髓瘤性骨病的 ADC 平均值为 1054±456×10⁻⁶mm²s⁻¹。ADC 阈值为 655×10⁻⁶mm²s⁻¹,可将正常和异常骨髓分开,其敏感性和特异性分别为 90%和 93%。b 值为 1389 smm⁻²时,正常和异常骨髓之间的对比度最佳。

结论

骨 ADC 测量的可重复性与软组织的已发表数据相当,具有很高的敏感性和特异性,可将异常与年龄匹配的正常骨髓分开。b 值约为 1400 smm⁻²时,对骨髓成像最佳。

相似文献

1
Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility.优化扩散加权 MRI 成像,以诊断转移性和骨髓瘤骨病,并评估其可重复性。
Eur Radiol. 2011 Aug;21(8):1713-8. doi: 10.1007/s00330-011-2116-4. Epub 2011 Apr 7.
2
Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI.评估弥散加权 MRI 中骨髓信号强度与表观弥散系数之间的关系。
AJR Am J Roentgenol. 2013 Jan;200(1):163-70. doi: 10.2214/AJR.11.8185.
3
Assessing response of myeloma bone disease with diffusion-weighted MRI.用弥散加权 MRI 评估骨髓瘤骨病的反应。
Br J Radiol. 2012 Dec;85(1020):e1198-203. doi: 10.1259/bjr/52759767.
4
Quantitative Diffusion-weighted Imaging of the Bone Marrow: An Adjunct Tool for the Diagnosis of a Diffuse MR Imaging Pattern in Patients with Multiple Myeloma.骨髓定量扩散加权成像:多发性骨髓瘤患者弥漫性 MRI 表现的辅助诊断工具。
Radiology. 2017 Feb;282(2):484-493. doi: 10.1148/radiol.2016160363. Epub 2016 Sep 9.
5
Application value of diffusion weighted whole body imaging with background body signal suppression in monitoring the response to treatment of bone marrow involvement in lymphoma.背景体素信号抑制的扩散加权全身成像在监测淋巴瘤骨髓受累治疗反应中的应用价值
J Magn Reson Imaging. 2016 Dec;44(6):1522-1529. doi: 10.1002/jmri.25300. Epub 2016 May 10.
6
Apparent diffusion coefficient of vertebral haemangiomas allows differentiation from malignant focal deposits in whole-body diffusion-weighted MRI.椎体血管瘤的表观扩散系数可在全身弥散加权 MRI 中区分恶性局灶性沉积物。
Eur Radiol. 2018 Apr;28(4):1687-1691. doi: 10.1007/s00330-017-5079-2. Epub 2017 Nov 13.
7
Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging of focal vertebral bone marrow lesions: initial experience of the differentiation of nodular hyperplastic hematopoietic bone marrow from malignant lesions.局灶性椎体骨髓病变的体素内不相干运动扩散加权磁共振成像:结节性增生性造血骨髓与恶性病变鉴别的初步经验
Skeletal Radiol. 2017 May;46(5):675-683. doi: 10.1007/s00256-017-2603-z. Epub 2017 Mar 6.
8
Evaluation of Diffusion-weighted MR Imaging as a Technique for Detecting Bone Marrow Edema in Patients with Osteitis Pubis.扩散加权磁共振成像作为耻骨炎患者骨髓水肿检测技术的评估
Magn Reson Med Sci. 2017 Oct 10;16(4):317-324. doi: 10.2463/mrms.mp.2016-0104. Epub 2017 Feb 13.
9
Vertebral bone marrow diffusivity in normal adults with varying bone densities at 3T diffusion-weighted imaging.3T扩散加权成像下不同骨密度正常成年人的椎体骨髓扩散率
Acta Radiol. 2018 Jan;59(1):89-96. doi: 10.1177/0284185117704235. Epub 2017 Apr 14.
10
Detection of bone marrow metastases in children and young adults with solid cancers with diffusion-weighted MRI.应用弥散加权 MRI 检测儿童和青年实体瘤患者骨髓转移。
Skeletal Radiol. 2023 Jun;52(6):1179-1192. doi: 10.1007/s00256-022-04240-0. Epub 2022 Nov 28.

引用本文的文献

1
ADC measurement in whole-body MRI for multiple myeloma: a three b-values vs. two b-values DWI comparison.全身MRI中用于多发性骨髓瘤的表观扩散系数(ADC)测量:三种b值与两种b值扩散加权成像(DWI)的比较
Radiol Med. 2025 Jun 3. doi: 10.1007/s11547-025-02026-7.
2
The value of multiparametric functional MRI histogram features in assessing multiple myeloma activity.多参数功能磁共振成像直方图特征在评估多发性骨髓瘤活性中的价值。
Eur Radiol. 2025 Mar 18. doi: 10.1007/s00330-025-11507-2.
3
F-FDG PET/CT and MRI in the Management of Multiple Myeloma: A Comparative Review.

本文引用的文献

1
Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations.前列腺癌骨转移:利用弥散加权成像和功能弥散图评估治疗反应——初步观察。
Radiology. 2010 Nov;257(2):523-31. doi: 10.1148/radiol.10092469. Epub 2010 Sep 9.
2
Evaluation of MR spectroscopy and diffusion-weighted MRI in detecting bone marrow changes in postmenopausal women with osteoporosis.评估磁共振波谱和弥散加权成像在绝经后骨质疏松症妇女骨髓变化中的应用。
Clin Radiol. 2010 May;65(5):377-81. doi: 10.1016/j.crad.2009.12.011. Epub 2010 Mar 23.
3
Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma.
18F-氟脱氧葡萄糖正电子发射断层显像/计算机断层扫描与磁共振成像在多发性骨髓瘤治疗中的应用:一项比较性综述
Front Nucl Med. 2022 Feb 22;1:808627. doi: 10.3389/fnume.2021.808627. eCollection 2021.
4
Present and future of whole-body MRI in metastatic disease and myeloma: how and why you will do it.全身 MRI 在转移疾病和骨髓瘤中的现状与未来:如何以及为何您将使用它。
Skeletal Radiol. 2024 Sep;53(9):1815-1831. doi: 10.1007/s00256-024-04723-2. Epub 2024 Jul 15.
5
Repeatability of quantitative individual lesion and total disease multiparametric whole-body MRI measurements in prostate cancer bone metastases.前列腺癌骨转移定量个体病变和总疾病多参数全身 MRI 测量的可重复性。
Br J Radiol. 2023 Nov;96(1151):20230378. doi: 10.1259/bjr.20230378. Epub 2023 Sep 3.
6
Evaluation of MRI in the diagnostic accuracy of extrahepatic metastases in neuroendocrine tumors in comparison with the reference standard somatostatin-receptor-PET/CT.与参考标准生长抑素受体PET/CT相比,评估MRI对神经内分泌肿瘤肝外转移的诊断准确性。
Front Oncol. 2023 Aug 15;13:1194152. doi: 10.3389/fonc.2023.1194152. eCollection 2023.
7
Diffusion-Weighted MRI for Treatment Response Assessment in Osteoblastic Metastases-A Repeatability Study.扩散加权磁共振成像用于成骨性转移瘤治疗反应评估的重复性研究
Cancers (Basel). 2023 Jul 25;15(15):3757. doi: 10.3390/cancers15153757.
8
An MRI-based radiomics nomogram for differentiating spinal metastases from multiple myeloma.基于 MRI 的放射组学列线图用于区分脊柱转移瘤和多发性骨髓瘤。
Cancer Imaging. 2023 Jul 24;23(1):72. doi: 10.1186/s40644-023-00585-4.
9
Hybrid simultaneous whole-body 2-[F]FDG-PET/MRI imaging in newly diagnosed multiple myeloma: first diagnostic performance and clinical added value results.新型多发性骨髓瘤患者的 Hybrid 同步全身 2-[F]FDG-PET/MRI 成像:初步诊断性能和临床附加价值结果。
Eur Radiol. 2023 Sep;33(9):6438-6447. doi: 10.1007/s00330-023-09593-1. Epub 2023 Apr 6.
10
[Imaging for Multiple Myeloma according to the Recent International Myeloma Working Group Guidelines: Analysis of Image Acquisition Techniques and Response Evaluation in Whole-Body MRI according to MY-RADS].[根据国际骨髓瘤工作组最新指南的多发性骨髓瘤成像:根据MY-RADS分析全身MRI的图像采集技术和反应评估]
J Korean Soc Radiol. 2023 Jan;84(1):150-169. doi: 10.3348/jksr.2021.0179. Epub 2022 May 23.
全身磁共振弥散加权成像与骨扫描在前列腺癌或乳腺癌患者骨转移检测中的比较。
Skeletal Radiol. 2010 Apr;39(4):333-43. doi: 10.1007/s00256-009-0789-4.
4
Diffusion Weighted Magnetic Resonance Imaging of metastatic bone disease: A biomarker for treatment response monitoring.弥散加权磁共振成像在转移性骨疾病中的应用:治疗反应监测的生物标志物。
Cancer Biomark. 2010;6(1):21-32. doi: 10.3233/CBM-2009-0116.
5
Detection of bone metastases using diffusion weighted magnetic resonance imaging: comparison with (11)C-methionine PET and bone scintigraphy.应用弥散加权磁共振成像检测骨转移:与(11)C-蛋氨酸 PET 和骨闪烁扫描的比较。
Magn Reson Imaging. 2010 Apr;28(3):372-9. doi: 10.1016/j.mri.2009.12.008. Epub 2010 Jan 27.
6
Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial.在一项两中心的 I 期临床试验中,用 combretastatin A4 磷酸盐和贝伐单抗治疗的实体瘤的表观扩散系数的重现性和变化。
Eur Radiol. 2009 Nov;19(11):2728-38. doi: 10.1007/s00330-009-1469-4. Epub 2009 Jun 23.
7
Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases.前列腺癌:扩散加权成像作为检测骨转移的传统磁共振成像和11C-胆碱正电子发射断层扫描/计算机断层扫描的潜在替代方法。
Radiology. 2008 Dec;249(3):1017-25. doi: 10.1148/radiol.2492080038. Epub 2008 Oct 10.
8
A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone.一项可行性研究,评估功能扩散图谱作为检测转移性前列腺癌骨转移患者治疗反应的预测性成像生物标志物。
Neoplasia. 2007 Dec;9(12):1003-11. doi: 10.1593/neo.07954.
9
Quantitative and diffusion MR imaging as a new method to assess osteoporosis.定量及扩散磁共振成像作为评估骨质疏松症的一种新方法。
AJNR Am J Neuroradiol. 2007 Nov-Dec;28(10):1934-7. doi: 10.3174/ajnr.A0704. Epub 2007 Sep 28.
10
Diffusion-weighted MRI in the body: applications and challenges in oncology.体部扩散加权磁共振成像:肿瘤学中的应用与挑战
AJR Am J Roentgenol. 2007 Jun;188(6):1622-35. doi: 10.2214/AJR.06.1403.